- Home
- NCSM vs WHWK Comparison
NCSM vs WHWK Comparison
Compare NCSM & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCSM
- WHWK
- Stock Information
- Founded
- NCSM 2006
- WHWK 2007
- Country
- NCSM United States
- WHWK United States
- Employees
- NCSM N/A
- WHWK N/A
- Industry
- NCSM Oilfield Services/Equipment
- WHWK Biotechnology: Pharmaceutical Preparations
- Sector
- NCSM Energy
- WHWK Health Care
- Exchange
- NCSM Nasdaq
- WHWK Nasdaq
- Market Cap
- NCSM 76.3M
- WHWK 82.4M
- IPO Year
- NCSM 2017
- WHWK N/A
- Fundamental
- Price
- NCSM $34.84
- WHWK $1.60
- Analyst Decision
- NCSM
- WHWK
- Analyst Count
- NCSM 0
- WHWK 0
- Target Price
- NCSM N/A
- WHWK N/A
- AVG Volume (30 Days)
- NCSM 6.1K
- WHWK 69.3K
- Earning Date
- NCSM 07-31-2025
- WHWK 08-07-2025
- Dividend Yield
- NCSM N/A
- WHWK N/A
- EPS Growth
- NCSM N/A
- WHWK N/A
- EPS
- NCSM 4.71
- WHWK N/A
- Revenue
- NCSM $175,468,000.00
- WHWK $21,596,000.00
- Revenue This Year
- NCSM $7.17
- WHWK $49.83
- Revenue Next Year
- NCSM $5.44
- WHWK N/A
- P/E Ratio
- NCSM $7.40
- WHWK N/A
- Revenue Growth
- NCSM 19.31
- WHWK N/A
- 52 Week Low
- NCSM $16.81
- WHWK $1.39
- 52 Week High
- NCSM $38.95
- WHWK $3.81
- Technical
- Relative Strength Index (RSI)
- NCSM 63.78
- WHWK N/A
- Support Level
- NCSM $31.78
- WHWK N/A
- Resistance Level
- NCSM $34.07
- WHWK N/A
- Average True Range (ATR)
- NCSM 1.65
- WHWK 0.00
- MACD
- NCSM 0.27
- WHWK 0.00
- Stochastic Oscillator
- NCSM 83.49
- WHWK 0.00
About NCSM NCS Multistage Holdings Inc.
NCS Multistage Holdings Inc is a provider of engineered products and support services that facilitate the optimization of oil and natural gas well construction, well completions and field development strategies. NCS provides its products and services to exploration and production companies for use in onshore wells, predominantly wells that have been drilled with horizontal laterals in unconventional oil and natural gas formations. The company's offering is its fracturing systems products and services, which enable efficient pinpoint stimulation: the process of individually stimulating each entry point into a formation targeted by an oil or natural gas well. It sell products and services in North America and in selected international markets.
About WHWK Whitehawk Therapeutics Inc. Common Stock
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.